Eric dEsparbes
CIK 1622268 · Chief Financial Officer · last filed 2024-08-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.57M
Companies
4
Total Filings
35
Lifetime Open-Market Net
-$504.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIORA THERAPEUTICS, INC. (BIOR) Delisted | Chief Financial Officer | 575,832 | $0.22 | $126.7K | $0 | 10 | 2024-08-16 |
| BIORA THERAPEUTICS, INC. (PROG) Delisted | Chief Financial Officer | 423,171 | $0.88 | $374.3K | $0 | 9 | 2022-04-19 |
| INVA | SVP and CFO | 376,965 | $22.74 | $8.57M | -$504.5K | 13 | 2018-05-22 |
| Innoviva, Inc. (THRX) Delisted | SVP and CFO | 132,779 | $4.06 | $539.1K | $0 | 3 | 2015-11-23 |
Recent Filings · Page 3 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-06 | INVA | Grant (A) | +93,056 | $0 | EDGAR |
| 2018-02-22 | INVA | Mixed | −30,254 | -$497.8K | EDGAR |
| 2017-11-22 | INVA | Mixed | −21,426 | -$283.8K | EDGAR |
| 2017-08-22 | INVA | Mixed | −7,595 | -$93.1K | EDGAR |
| 2017-05-23 | INVA | Mixed | −6,033 | -$71.5K | EDGAR |
| 2017-02-22 | INVA | Mixed | −10,429 | -$125.6K | EDGAR |
| 2017-01-19 | INVA | Grant (A) | +133,398 | $0 | EDGAR |
| 2016-11-22 | INVA | Mixed | −5,632 | -$61.4K | EDGAR |
| 2016-08-23 | INVA | Mixed | −6,545 | -$77.1K | EDGAR |
| 2016-05-20 | INVA | Tax (F) | −2,818 | -$31.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.